A single vial of blood could help tell you which drugs to take, foods to eat, and more.

In a proof-of-concept study, the test successfully identified five critical biomarkers associated with Alzheimer’s disease, exceeding the capabilities of currently available commercial blood tests. Re ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research ...

SeekIn has announced the clinical validation of its non-invasive multi-omics blood test, SeekInCare, intended for the early identification of various cancers, in a study published in the Journal ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from a patient. “Alzheimer’s disease impacts too many people, more than ...

The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...

The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing Friday, meaning the laboratory test can be marketed and sold in the U.S ...

The test is for older Americans already exhibiting signs of Alzheimer's. The Food and Drug Administration (FDA) cleared the first blood test on Friday to help diagnose Alzheimer's disease.

Fujirebio Diagnostics designed the blood test to help detect Alzheimer’s disease early, when interventions are more effective, president and CEO Monte Wiltse said in a news release last year ...

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients ...